New Speciality Standards New Speciality Standards Management of End Stage Ankle Arthritis 05 April 2025 Click here to access the latest BOFAS-BOA Standards for management of End Stage Ankle Arthritis Read more
Memorandum of Understanding with Royal College of Podiatry Memorandum of Understanding with Royal College of Podiatry 12 November 2024 The MOU between the RCP and BOFAS is a landmark document outlining similarities and differences between the two professional groups. This is pertinent to all surgeons and patients. Click for more details. Read more
Australian Orthopaedic F&A Society Australian Orthopaedic F&A Society Seeking Expressions of Interest for August 2026 11 November 2024 The Australian Orthopaedic Foot & Ankle Society is seeking expressions of interest from BOFAS Members interested in joining their 2026 annual meeting in Singapore. Read more
20Apr2026 BOFAS Diabetic Foot Principles Course 20/04/2026 Read more BOFAS Diabetic Foot Principles Course 20th April 2026, Delta by Marriott Hotel, Milton Keynes £150.00 Read more
29Apr2026 BOFAS Trauma Course 29/04/2026 Read more BOFAS Trauma Course 29th April 2026, Bristol £150 Read more
15May2026 BOFAS Allied Health Professionals Course 15/05/2026 Read more BOFAS Allied Health Professionals Course 15th May 2026, Bournemouth Read more
2Jul2026 BOFAS Basics & Advanced Arthroscopy Skills Course 02/07/2026 Read more BOFAS Basics & Advanced Arthroscopy Skills Course 2nd-3rd July 2026, Solihull Read more
1Oct2026 BOFAS Principles Course 01/10/2026 Read more BOFAS Principles Course 1st-2nd October 2026, Glasgow £325.00 Read more
6May2026 Nordic Foot & Ankle Congress 06/05/2026 - 07/05/2026 Read more Nordic Foot & Ankle Congress BOFAS Members have been invited to the Nordic Foot & Ankle Congress May 6/7 2026 in Oslo. Read more
Togay Koç / 27 June 2022 / Categories: Abstracts, 2013, Poster Morton’s neuroma: the clinical picture revisited D. Mahadevan, M. Venkatesan, R. Bhatt, M. Bhatia Introduction: Various tests to clnically detect Morton´s neuroma (MN) have been described but none are pathognomonic and the most reliable technique has yet to be established. Methods: A prospective study was undertaken on 54 feet with symptomatic Morton’s neuroma (MN) to identify the most common reported symptoms and clinical signs. Patients in a foot and ankle clinic with features of MN had their symptoms and clinical signs recorded. An ultrasound was subsequently performed by a radiologist who was kept blind to clinical findings. Results: MN was detected on ultrasound at the site of symptoms in all but one case. Adjacent webspace neuromas were symptomatic in 27% and asymptomatic in 5%. Forefoot pain was the presenting feature in 96% and 72% characterised the pain as burning. 60% complained of altered sensation. The sensation of ´like having a pebble in the shoe´ was reported in only 52%. The thumb-index-finger squeeze test was the most consistent clinical finding (94%). Mulder’s click was only positive in 63% and was size dependent (10.9mm in positive tests vs. 8.5mm in negative tests, p=0.016). Other tests were less consistent and were positive in 42% for foot squeeze, 35% for plantar percussion, 31% for dorsal percussion and 28% for sensory changes. Results: The diagnosis of MN can be reliably made through clinical assessment (98% chance of having an ultrasound detectable MN). A history of forefoot ‘burning’ pain with a positive thumb-index-finger squeeze test may be considered as pathognomonic of MN. Print 1290 Tags: Clinical Test